New cancer drug enters human trials, aims to shrink advanced tumors
Disease control
Recruiting now
This early-stage study is testing a new drug called NUC-7738 in adults with advanced cancers that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors, either by itself or combined with another immunotherapy drug.…
Phase: PHASE1, PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC